{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T23:19:20Z","timestamp":1768864760964,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Changsha Natural Science Foundation Project","award":["No. kq2208447"],"award-info":[{"award-number":["No. kq2208447"]}]},{"name":"Changsha Natural Science Foundation Project","award":["No. kq2208447"],"award-info":[{"award-number":["No. kq2208447"]}]},{"name":"Changsha Natural Science Foundation Project","award":["No. kq2208447"],"award-info":[{"award-number":["No. kq2208447"]}]},{"name":"Changsha Natural Science Foundation Project","award":["No. kq2208447"],"award-info":[{"award-number":["No. kq2208447"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chromosoma"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00412-025-00832-6","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:31:15Z","timestamp":1752139875000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RAD18 promotes cell malignant behaviors of esophageal squamous cell carcinoma by modulating ATM\/STAT3\/PD-L1"],"prefix":"10.1007","volume":"134","author":[{"given":"Xianghui","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qishi","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"issue":"2","key":"832_CR1","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1053\/j.gastro.2017.08.023","volume":"154","author":"CC Abnet","year":"2018","unstructured":"Abnet CC, Arnold M, Wei WQ (2018) Epidemiology of esophageal squamous cell carcinoma. Gastroenterology 154(2):360\u2013373","journal-title":"Gastroenterology"},{"issue":"2","key":"832_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1309\/JTKGGGKURFX3XMGT","volume":"121","author":"S Ang\u00e8le","year":"2004","unstructured":"Ang\u00e8le S et al (2004) ATM protein overexpression in prostate tumors: possible role in telomere maintenance. Am J Clin Pathol 121(2):231\u2013236","journal-title":"Am J Clin Pathol"},{"key":"832_CR3","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3389\/fgene.2018.00611","volume":"9","author":"M Chen","year":"2018","unstructured":"Chen M et al (2018) Long noncoding RNA FAM201A mediates the radiosensitivity of esophageal squamous cell Cancer by regulating ATM and mTOR expression via miR-101. Front Genet 9:611","journal-title":"Front Genet"},{"issue":"37","key":"832_CR4","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1038\/s41388-023-02781-9","volume":"42","author":"S Chen","year":"2023","unstructured":"Chen S et al (2023) JMJD6 in tumor-associated macrophage regulates macrophage polarization and cancer progression via STAT3\/IL-10 axis. Oncogene 42(37):2737\u20132750","journal-title":"Oncogene"},{"issue":"26","key":"832_CR5","first-page":"3351","volume":"33","author":"CA Cremona","year":"2014","unstructured":"Cremona CA, Behrens A (2014) ATM Signal cancer Oncogene 33(26):3351\u20133360","journal-title":"ATM Signal cancer Oncogene"},{"key":"832_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3389\/fonc.2017.00291","volume":"7","author":"ES Dahl","year":"2017","unstructured":"Dahl ES, Aird KM (2017) Ataxia-Telangiectasia mutated modulation of carbon metabolism in Cancer. Front Oncol 7:291","journal-title":"Front Oncol"},{"issue":"10","key":"832_CR7","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41568-021-00365-x","volume":"21","author":"B Dale","year":"2021","unstructured":"Dale B et al (2021) Advancing targeted protein degradation for cancer therapy. Nat Rev Cancer 21(10):638\u2013654","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"832_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.14423\/SMJ.0000000000001226","volume":"114","author":"M DiSiena","year":"2021","unstructured":"DiSiena M et al (2021) Esophageal cancer: an updated review. South Med J 114(3):161\u2013168","journal-title":"South Med J"},{"issue":"6","key":"832_CR9","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1083\/jcb.201311007","volume":"205","author":"J Han","year":"2014","unstructured":"Han J et al (2014) SIVA1 directs the E3 ubiquitin ligase RAD18 for PCNA monoubiquitination. J Cell Biol 205(6):811\u2013827","journal-title":"J Cell Biol"},{"issue":"4","key":"832_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41419-022-04751-7","volume":"13","author":"D Hanisch","year":"2022","unstructured":"Hanisch D et al (2022) Class I HDAC overexpression promotes Temozolomide resistance in glioma cells by regulating RAD18 expression. Cell Death Dis 13(4):293","journal-title":"Cell Death Dis"},{"issue":"10","key":"832_CR11","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/cac2.12192","volume":"41","author":"F Ji","year":"2021","unstructured":"Ji F et al (2021) Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis. Cancer Commun (Lond) 41(10):1007\u20131023","journal-title":"Cancer Commun (Lond)"},{"issue":"8","key":"832_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s12272-022-01398-y","volume":"45","author":"E Khatoon","year":"2022","unstructured":"Khatoon E et al (2022) The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer. Arch Pharm Res 45(8):507\u2013534","journal-title":"Arch Pharm Res"},{"issue":"12","key":"832_CR13","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41580-021-00394-2","volume":"22","author":"JH Lee","year":"2021","unstructured":"Lee JH, Paull TT (2021) Cellular functions of the protein kinase ATM and their relevance to human disease. Nat Rev Mol Cell Biol 22(12):796\u2013814","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"832_CR14","first-page":"213","volume":"44","author":"P Li","year":"2020","unstructured":"Li P et al (2020) RAD18 promotes colorectal cancer metastasis by activating the epithelial\u2013mesenchymal transition pathway. Oncol Rep 44(1):213\u2013223","journal-title":"Oncol Rep"},{"issue":"20","key":"832_CR15","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1002\/cam4.4754","volume":"11","author":"X Li","year":"2022","unstructured":"Li X et al (2022) RAD18 confers radioresistance of esophagus squamous cell carcinoma through regulating p-DNA-PKcs. Cancer Med 11(20):3809\u20133819","journal-title":"Cancer Med"},{"key":"832_CR16","doi-asserted-by":"publisher","first-page":"104353","DOI":"10.1016\/j.ebiom.2022.104353","volume":"86","author":"TT Liu","year":"2022","unstructured":"Liu TT et al (2022) Atypical E3 ligase ZFP91 promotes small-molecule-induced E2F2 transcription factor degradation for cancer therapy. EBioMedicine 86:104353","journal-title":"EBioMedicine"},{"key":"832_CR17","doi-asserted-by":"crossref","unstructured":"Liu J et al (2023) The ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer. J Clin Invest, 133(6): e164354","DOI":"10.1172\/JCI164354"},{"issue":"4","key":"832_CR18","first-page":"3415","volume":"20","author":"P Lou","year":"2019","unstructured":"Lou P et al (2019) RAD18 contributes to the migration and invasion of human cervical cancer cells via the interleukin\u20131\u03b2 pathway. Mol Med Rep 20(4):3415\u20133423","journal-title":"Mol Med Rep"},{"issue":"3","key":"832_CR19","doi-asserted-by":"publisher","first-page":"e1291106","DOI":"10.1080\/2162402X.2017.1291106","volume":"6","author":"C Lu","year":"2017","unstructured":"Lu C et al (2017) JAK-STAT-mediated chronic inflammation impairs cytotoxic T lymphocyte activation to decrease anti-PD-1 immunotherapy efficacy in pancreatic cancer. Oncoimmunology 6(3):e1291106","journal-title":"Oncoimmunology"},{"issue":"12","key":"832_CR20","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.7150\/ijbs.87182","volume":"19","author":"J Lv","year":"2023","unstructured":"Lv J et al (2023) Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3\/PD-L1 cascade. Int J Biol Sci 19(12):3744\u20133761","journal-title":"Int J Biol Sci"},{"key":"832_CR21","doi-asserted-by":"crossref","unstructured":"Ma RJ et al (2022) Molecular mechanism, regulation, and therapeutic targeting of the STAT3 signaling pathway in esophageal cancer (Review). Int J Oncol, 61(3): 105","DOI":"10.3892\/ijo.2022.5395"},{"issue":"2","key":"832_CR22","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.eururo.2020.10.029","volume":"79","author":"A Neeb","year":"2021","unstructured":"Neeb A et al (2021) Advanced prostate Cancer with ATM loss: PARP and ATR inhibitors. Eur Urol 79(2):200\u2013211","journal-title":"Eur Urol"},{"issue":"4","key":"832_CR23","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1096\/fj.14-262527","volume":"29","author":"JM Overstreet","year":"2015","unstructured":"Overstreet JM et al (2015) Tumor suppressor ataxia telangiectasia mutated functions downstream of TGF-\u03b21 in orchestrating profibrotic responses. Faseb J 29(4):1258\u20131268","journal-title":"Faseb J"},{"issue":"51","key":"832_CR24","doi-asserted-by":"publisher","first-page":"7776","DOI":"10.1038\/sj.onc.1205981","volume":"21","author":"J Pamment","year":"2002","unstructured":"Pamment J et al (2002) Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway. Oncogene 21(51):7776\u20137785","journal-title":"Oncogene"},{"issue":"5","key":"832_CR25","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.surg.2012.03.025","volume":"152","author":"M Ruteg\u00e5rd","year":"2012","unstructured":"Ruteg\u00e5rd M et al (2012) Population-based esophageal cancer survival after resection without neoadjuvant therapy: an update. Surgery 152(5):903\u2013910","journal-title":"Surgery"},{"issue":"1","key":"832_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13046-019-1161-8","volume":"38","author":"M Shen","year":"2019","unstructured":"Shen M et al (2019) Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK\/STAT3\/PD-L1 pathway. J Exp Clin Cancer Res 38(1):149","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"832_CR27","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H et al (2021) Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"832_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40170-023-00320-4","volume":"11","author":"C Terlizzi","year":"2023","unstructured":"Terlizzi C et al (2023) ATM Inhibition blocks glucose metabolism and amplifies the sensitivity of resistant lung cancer cell lines to oncogene driver inhibitors. Cancer Metab 11(1):20","journal-title":"Cancer Metab"},{"issue":"19","key":"832_CR29","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.1182\/blood-2010-10-311761","volume":"117","author":"SA Williams","year":"2011","unstructured":"Williams SA et al (2011) The E3 ubiquitin ligase RAD18 regulates ubiquitylation and chromatin loading of FANCD2 and FANCI. Blood 117(19):5078\u20135087","journal-title":"Blood"},{"issue":"2","key":"832_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1755-148X.2011.00948.x","volume":"25","author":"RP Wong","year":"2012","unstructured":"Wong RP et al (2012) Elevated expression of Rad18 regulates melanoma cell proliferation. Pigment Cell Melanoma Res 25(2):213\u2013218","journal-title":"Pigment Cell Melanoma Res"},{"issue":"1","key":"832_CR31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s13046-019-1310-0","volume":"38","author":"J Wu","year":"2019","unstructured":"Wu J et al (2019) IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma. J Exp Clin Cancer Res 38(1):321","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"832_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41418-020-0596-y","volume":"28","author":"N Wu","year":"2021","unstructured":"Wu N et al (2021) LINC00941 promotes CRC metastasis through preventing SMAD4 protein degradation and activating the TGF-\u03b2\/SMAD2\/3 signaling pathway. Cell Death Differ 28(1):219\u2013232","journal-title":"Cell Death Differ"},{"issue":"11","key":"832_CR33","doi-asserted-by":"publisher","first-page":"21100","DOI":"10.1002\/jcp.28713","volume":"234","author":"C Xie","year":"2019","unstructured":"Xie C et al (2019) Knockdown of RAD18 inhibits glioblastoma development. J Cell Physiol 234(11):21100\u201321112","journal-title":"J Cell Physiol"},{"issue":"7","key":"832_CR34","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/15384101.2018.1456296","volume":"17","author":"Y Yang","year":"2018","unstructured":"Yang Y et al (2018) Diverse roles of RAD18 and Y-family DNA polymerases in tumorigenesis. Cell Cycle 17(7):833\u2013843","journal-title":"Cell Cycle"},{"issue":"Pt 2","key":"832_CR35","doi-asserted-by":"publisher","first-page":"117241","DOI":"10.1016\/j.jep.2023.117241","volume":"319","author":"Y Yang","year":"2024","unstructured":"Yang Y et al (2024) Gancao Xiexin Decoction inhibits gastric carcinoma proliferation and migration by regulating the JAK2\/STAT3 signalling pathway. J Ethnopharmacol 319(Pt 2):117241","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"832_CR36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01489-2","volume":"21","author":"M Yi","year":"2022","unstructured":"Yi M et al (2022) Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions. Mol Cancer 21(1):28","journal-title":"Mol Cancer"},{"issue":"4","key":"832_CR37","doi-asserted-by":"publisher","first-page":"8000","DOI":"10.1080\/21655979.2022.2048991","volume":"13","author":"X Zeng","year":"2022","unstructured":"Zeng X et al (2022) UBE2B promotes ovarian cancer growth via promoting RAD18 mediated ZMYM2 monoubiquitination and stabilization. Bioengineered 13(4):8000\u20138012","journal-title":"Bioengineered"},{"issue":"7","key":"832_CR38","doi-asserted-by":"publisher","first-page":"11642","DOI":"10.1002\/jcb.28444","volume":"120","author":"C Zhang","year":"2019","unstructured":"Zhang C et al (2019) Upregulation of long noncoding RNA SNHG20 promotes cell growth and metastasis in esophageal squamous cell carcinoma via modulating ATM-JAK-PD-L1 pathway. J Cell Biochem 120(7):11642\u201311650","journal-title":"J Cell Biochem"},{"key":"832_CR39","doi-asserted-by":"publisher","first-page":"9539","DOI":"10.2147\/CMAR.S261182","volume":"12","author":"R Zhang","year":"2020","unstructured":"Zhang R et al (2020) EphA5 Silencing increases the radiosensitivity of ESCC cells through ATM-Dependent pathway. Cancer Manag Res 12:9539\u20139549","journal-title":"Cancer Manag Res"},{"issue":"24","key":"832_CR40","doi-asserted-by":"publisher","first-page":"11157","DOI":"10.1111\/jcmm.17037","volume":"25","author":"S Zhou","year":"2021","unstructured":"Zhou S et al (2021) MET Inhibition enhances PARP inhibitor efficacy in castration-resistant prostate cancer by suppressing the ATM\/ATR and PI3K\/AKT pathways. J Cell Mol Med 25(24):11157\u201311169","journal-title":"J Cell Mol Med"},{"issue":"47","key":"832_CR41","doi-asserted-by":"publisher","first-page":"eadg2263","DOI":"10.1126\/sciadv.adg2263","volume":"9","author":"Y Zhou","year":"2023","unstructured":"Zhou Y et al (2023a) ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer. Sci Adv 9(47):eadg2263","journal-title":"Sci Adv"},{"issue":"5","key":"832_CR42","doi-asserted-by":"publisher","first-page":"112445","DOI":"10.1016\/j.celrep.2023.112445","volume":"42","author":"L Zhou","year":"2023","unstructured":"Zhou L et al (2023b) DUSP4 promotes esophageal squamous cell carcinoma progression by dephosphorylating HSP90\u03b2. Cell Rep 42(5):112445","journal-title":"Cell Rep"},{"key":"832_CR43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.canlet.2017.12.034","volume":"417","author":"S Zou","year":"2018","unstructured":"Zou S et al (2018) RAD18 promotes the migration and invasion of esophageal squamous cell cancer via the JNK-MMPs pathway. Cancer Lett 417:65\u201374","journal-title":"Cancer Lett"}],"container-title":["Chromosoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00412-025-00832-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00412-025-00832-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00412-025-00832-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T11:02:45Z","timestamp":1768820565000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00412-025-00832-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["832"],"URL":"https:\/\/doi.org\/10.1007\/s00412-025-00832-6","relation":{},"ISSN":["0009-5915","1432-0886"],"issn-type":[{"value":"0009-5915","type":"print"},{"value":"1432-0886","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"26 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"6"}}